#OpenAccess in @DiabetologiaJnl – ApoAI-derived peptide increases glucose tolerance and prevents formation of atherosclerosis in mice https://t.co/iT4qChXXRA https://t.co/xc8XqowkuW
RT @gerdosi: Wow, a short peptide sequence, RG54, derived from ApoA-I, increases glucose tolerance and prevents formation of atherosclerosi…
The RG54 peptide exhibits good prospects for providing glucose control and reducing the risk of cardiovascular disease in individuals with severe insulin resistance: #diabetes #glucosecontrol #cardiovascular https://t.co/JiMUJYiQRZ 🔓 https://t.co/86i5CPf8j
RT @gerdosi: Wow, a short peptide sequence, RG54, derived from ApoA-I, increases glucose tolerance and prevents formation of atherosclerosi…
Wow, a short peptide sequence, RG54, derived from ApoA-I, increases glucose tolerance and prevents formation of atherosclerosis in mice. https://t.co/gINt4sZ63p
RT @DanielJDrucker: Based on studies in cells and mice “the RG54 peptide derived from apolipoprotein A-I, exhibits good prospects for provi…
RT @DanielJDrucker: Based on studies in cells and mice “the RG54 peptide derived from apolipoprotein A-I, exhibits good prospects for provi…
Based on studies in cells and mice “the RG54 peptide derived from apolipoprotein A-I, exhibits good prospects for providing glucose control and reducing the risk of cardiovascular disease in individuals with severe #insulinresistance” @DiabetologiaJnl http